BURLINGTON, Mass., May 29, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) (the “Company”), a provider of peripheral vascular devices and implants, today announced that it has commenced an underwritten public offering of the Company’s common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. In addition, the Company expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of its common stock offered in the public offering to cover over-allotments, if any.
Help employers find you! Check out all the jobs and post your resume.
